Medical Communications

Showing 15 posts of 6402 posts found.

Redefining the value of medicines with patients at the centre

November 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, health economics and outcomes research, market access, pharma

Liz Lewis, Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology, discusses the importance and challenges of …
191101154915-stephen-hahn-fda-exlarge-169

Donald Trump nominates Dr Stephen Hahn as next FDA Commissioner

November 4, 2019 Medical Communications, Sales and Marketing Donald Trump, FDA, Ned Sharpless, President trump, Scott Gottlieb, Trump, US

The US FDA could be set to receive its next long-term Commissioner after the White House revealed President Donald Trump’s …
16285-a-female-doctor-examining-an-elderly-male-patient-pv

Current drugs are “poisoning” elderly patients due to insufficient trial data, House of Lords committee hears

November 1, 2019 Medical Communications, Research and Development elderly patients, pharma, trial diversity

Elderly patients are being put at risk by prescriptions for drugs which have not been properly tested in their age …
shutterstock_192094955_web

England’s antibiotic use is down, but antibiotic-resistant infections still spreading, report warns

November 1, 2019 Medical Communications, Research and Development Antibiotics, England, Review on antimicrobial resistance

A new report has revealed that GPs in England are writing fewer prescriptions for antibiotics, but this has done little …
shutterstock_87495637

Amgen drops $2.7bn to acquire stake in Chinese biotech in bid to expand in the region

November 1, 2019 Medical Communications, Research and Development, Sales and Marketing Amgen, BeiGene, Cancer, China, deal, oncology, pharma

Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid …

Despite some advantages, Novartis’ Cosentyx fails to outclass Humira in active psoriatic arthritis

November 1, 2019 Medical Communications, Research and Development Cosentyx, Humira, Novartis, active psoriatic arthritis, pharma

Novartis has announced new data drawn from a trial pitting Cosentyx (secukinumab) in head-to-head competition with AbbVie’s Humira (adalimumab) – …
shutterstock_273326141

Transactions in the pharma sector: Through the EU merger review looking-glass

October 31, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mergers, mergers and acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …
pharmafocus_november_2019_front_cover

The November 2019 issue of Pharmafocus is available to read for free online now!

October 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The latest monthly edition of Pharmafocus, the November issue, is available to read for free online now!
shutterstock_339308225

Deeper patient insights for stronger patient outcomes

October 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eyeforpharma, pharma

Patient insights are crucial. As you already know, they are the key to the creation of successful, targeted programmes and …
shutter

UKRI and BBSRC award £170m to 3 UK universities for biotech and biology PhD studentships

October 28, 2019 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, pharma, research

The Biotechnology and Biological Sciences Research Council (BBSRC) and UK Research and Innovation (UKRI) have awarded a funding injection of …
flag-map_of_nigeria

Almost 400 Nigerian medical dispensaries shut down for sub-standard practice

October 28, 2019 Manufacturing and Production, Medical Communications, Sales and Marketing Nigeria, pharma

Nigeria has seen almost 400 of its medicine dispensaries shut down over “unethical practices and lack of compliance, it has …
seattle_genetics

Seattle Genetics reports topline phase 3 HER2-Positive Breast Cancer Data

October 25, 2019 Medical Communications

Seattle Genetics, a strong competitor in the breast cancer space, has reported topline results in its phase 3 study evaluating …
top_10_photo

Top Ten most popular articles on Pharmafile.com this week

October 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s another end of the week here at Pharmafile and here we run down our top 10 articles and features …
biogen_logo

Biogen plans Alzheimer’s drug approval after initial research failure

October 25, 2019 Medical Communications

Biogen is planning to seek approval for its experimental drug aducanumab, that could potentially be first to treat Alzheimer’s and …
The Gateway to Local Adoption Series

Latest content